2013
DOI: 10.5935/abc.20130248
|View full text |Cite
|
Sign up to set email alerts
|

Back to Basics: PCSK9 as a New Target for the LDL Receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 10 publications
(17 reference statements)
0
2
0
Order By: Relevance
“…After the blood draw procedure volunteers, tests of total cholesterol, triglycerides and serum concentrations of LDL and HDL, C-reactive protein, latosterol, β-sitosterol, campesterol and plasma levels of PCSK9, also called convertase 1, an enzyme that interacts directly with LDL receptors, decreasing its metabolism [25]. In conclusion, consumption of short-term buttermilk significantly reduced total serum cholesterol and triglyceride concentrations.…”
Section: Hypocholesterolemic Activitymentioning
confidence: 86%
“…After the blood draw procedure volunteers, tests of total cholesterol, triglycerides and serum concentrations of LDL and HDL, C-reactive protein, latosterol, β-sitosterol, campesterol and plasma levels of PCSK9, also called convertase 1, an enzyme that interacts directly with LDL receptors, decreasing its metabolism [25]. In conclusion, consumption of short-term buttermilk significantly reduced total serum cholesterol and triglyceride concentrations.…”
Section: Hypocholesterolemic Activitymentioning
confidence: 86%
“…This auto-cleavage process of PCSK9 is crucial for both its activation and release from the endoplasmic reticulum. 11 , 14 PCSK9 binds to the LDLR and directs the receptors for lysosomal destruction, thus reducing their recycling and decreasing the removal rate of circulating LDL-C with a subsequent increase of the LDL-C levels in the blood. 11 , 15 – 19 Gain-of-function mutations of PCSK9 in humans are linked to hypercholesterolaemia and elevated risk of CAD, 20 , 21 whereas loss-of-function mutations of PCSK9 are linked to low LDL-C levels and reduced cardiovascular risk.…”
Section: Reviewmentioning
confidence: 99%